Transenterix's Outstanding Shares = 199M (No dilution in the future) Senhance is recently cleared by FDA and currently available for sale in the world
Titan Medical's Outstanding Shares = 324M + addt'l offering (min 72M- max 92M shares in the form of common stock + warrants) for a total of 396M-416M Sport is still in development and only God knows when it's going to be cleared by FDA, let alone starting making money
Can you spot the winner here? I rest my case. Good day.